Cargando…
Microscaled proteogenomic methods for precision oncology
Cancer proteogenomics promises new insights into cancer biology and treatment efficacy by integrating genomics, transcriptomics and protein profiling including modifications by mass spectrometry (MS). A critical limitation is sample input requirements that exceed many sources of clinically important...
Autores principales: | Satpathy, Shankha, Jaehnig, Eric J., Krug, Karsten, Kim, Beom-Jun, Saltzman, Alexander B., Chan, Doug W., Holloway, Kimberly R., Anurag, Meenakshi, Huang, Chen, Singh, Purba, Gao, Ari, Namai, Noel, Dou, Yongchao, Wen, Bo, Vasaikar, Suhas V., Mutch, David, Watson, Mark A., Ma, Cynthia, Ademuyiwa, Foluso O., Rimawi, Mothaffar F., Schiff, Rachel, Hoog, Jeremy, Jacobs, Samuel, Malovannaya, Anna, Hyslop, Terry, Clauser, Karl R., Mani, D. R., Perou, Charles M., Miles, George, Zhang, Bing, Gillette, Michael A., Carr, Steven A., Ellis, Matthew J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6985126/ https://www.ncbi.nlm.nih.gov/pubmed/31988290 http://dx.doi.org/10.1038/s41467-020-14381-2 |
Ejemplares similares
-
Kinase Inhibitor Pulldown Assay Identifies a Chemotherapy Response Signature in Triple-negative Breast Cancer Based on Purine-binding Proteins
por: Wang, Junkai, et al.
Publicado: (2023) -
Proteogenomic Markers of Chemotherapy Resistance and Response in Triple-Negative Breast Cancer
por: Anurag, Meenakshi, et al.
Publicado: (2022) -
Proteogenomic Landscape of Breast Cancer Tumorigenesis and Targeted Therapy
por: Krug, Karsten, et al.
Publicado: (2020) -
Proteogenomic integration reveals therapeutic targets in breast cancer xenografts
por: Huang, Kuan-lin, et al.
Publicado: (2017) -
Corrigendum: Proteogenomic integration reveals therapeutic targets in breast cancer xenografts
por: Huang, Kuan-lin, et al.
Publicado: (2017)